Tsao-Wei D - Search Results

1

A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma.

Tuscano JM, Maverakis E, Groshen S, Tsao-Wei D, Luxardi G, Merleev AA, Beaven A, DiPersio JF, Popplewell L, Chen R, Kirschbaum M, Schroeder MA, Newman EM. Tuscano JM, et al. Clin Cancer Res. 2019 Dec 1;25(23):7004-7013. doi: 10.1158/1078-0432.CCR-19-0438. Epub 2019 Sep 3. Clin Cancer Res. 2019. PMID: 31481504 Free PMC article. Clinical Trial.

2

Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.

Datar RH, Naritoku WY, Li P, Tsao-Wei D, Groshen S, Taylor CR, Imam SA. Datar RH, et al. Gynecol Oncol. 1999 Sep;74(3):338-45. doi: 10.1006/gyno.1999.5506. Gynecol Oncol. 1999. PMID: 10479490

3

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV. Salonga D, et al. Clin Cancer Res. 2000 Apr;6(4):1322-7. Clin Cancer Res. 2000. PMID: 10778957 Clinical Trial.

4

LEA.135 expression: an independent and favorable prognostic biomarker for patients with primary invasive breast cancer.

Liu D, Naritoku WY, Tsao-Wei D, Groshen S, Neville MA, Taylor CR, Cote RJ, Imam SA. Liu D, et al. Int J Cancer. 2000 May 20;89(3):224-9. doi: 10.1002/1097-0215(20000520)89:3<224::aid-ijc3>3.0.co;2-b. Int J Cancer. 2000. PMID: 10861497

5

LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.

Liu D, Baltayan A, Naritoku WY, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA. Liu D, et al. Anticancer Res. 2000 May-Jun;20(3A):1451-61. Anticancer Res. 2000. PMID: 10928056

6

Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy.

Formenti SC, Lieskovsky G, Skinner D, Tsao-Wei DD, Groshen S, Petrovich Z. Formenti SC, et al. Urology. 2000 Sep 1;56(3):453-8. doi: 10.1016/s0090-4295(00)00677-4. Urology. 2000. PMID: 10962314

7

Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.

Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei D, Markland FS. Zhou Q, et al. Breast Cancer Res Treat. 2000 Jun;61(3):249-60. doi: 10.1023/a:1006457903545. Breast Cancer Res Treat. 2000. PMID: 10966001

8

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

Safra T, Muggia F, Jeffers S, Tsao-Wei DD, Groshen S, Lyass O, Henderson R, Berry G, Gabizon A. Safra T, et al. Ann Oncol. 2000 Aug;11(8):1029-33. doi: 10.1023/a:1008365716693. Ann Oncol. 2000. PMID: 11038041 Free article.

9

Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.

Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman L, Morrow CP, Burnett A, Muggia FM. Safra T, et al. Cancer. 2001 Jan 1;91(1):90-100. Cancer. 2001. PMID: 11148564 Clinical Trial.

10

Follicular lesions of thyroid: a 5-year fine-needle aspiration experience.

Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE. Greaves TS, et al. Cancer. 2000 Dec 25;90(6):335-41. Cancer. 2000. PMID: 11156516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters